2m 2m 2m 2m 2m 2m 2m
SURROZEN (SRZN)
NASDAQ
$24.60+$0.03 (+0.12%)
Price as of Jun 03, 2026 4:10 PM EDT- $304.3MMarket Cap
- 195.67%1-Year Change
- BiotechnologyIndustry
SURROZEN (SRZN)
$24.60+$0.03 (+0.12%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 3.5M -67.37% | 10.7M +4,321.16% | 241,000 +297.54% | -122,000 +2.52% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 3.5M -67.37% | 10.7M +4,321.16% | 241,000 +297.54% | -122,000 +2.52% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -29.4M +38.96% | -21.1M -22.39% | -27.2M -26.43% | -37.0M -7.88% | |
Depreciation and Amortization Expense | 537,000 -62.76% | 1.4M -24.54% | 1.9M -2.25% | 2.0M -5.37% | |
Total Operating Expenses | 45.6M +25.90% | 36.2M -20.94% | 45.8M -19.46% | 56.8M +4.50% | |
Operating Profit | -42.1M +64.81% | -25.5M -44.21% | -45.8M +3.25% | -44.3M -18.48% | |
Interest Income | 3.0M +78.38% | 1.7M -27.65% | 2.3M +199.62% | 781,000 +984.72% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 3.0M +78.38% | 1.7M -27.65% | 2.3M +199.62% | 781,000 +984.72% | |
Total Nonoperating Income and Expense | -26.3M +36.18% | -19.3M -4,954.52% | 398,000 -94.73% | 7.6M +2,396.05% | |
Income before Taxes | -42.1M +64.81% | -25.5M -44.21% | -45.8M +3.25% | -44.3M -18.48% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | 100,000 0.00% | 100,000 N/A | N/A N/A | |
Net Income | -242.0M +280.76% | -63.6M +47.68% | -43.0M +19.55% | -36.0M -34.12% | |
Net Income from Continuing Operations Applicable to Common | -242.0M +280.76% | -63.6M +47.68% | -43.0M +19.55% | -36.0M -34.12% | |
Basic EPS and Net Income | -32.37 +49.38% | -21.67 +1.59% | -21.33 +1,950.96% | -1.04 N/A | |
Diluted EPS and Net Income | -32.37 +49.38% | -21.67 +1.59% | -21.33 +1,950.96% | -1.04 N/A | |
Basic Weighted Average Shares | 7,478 +154.96% | 2,933 +45.34% | 2,018 -94.19% | 34,722 -99.86% | |
Diluted Weighted Average Shares | 7,478 +154.96% | 2,933 +45.34% | 2,018 -94.19% | 34,722 -99.86% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 89.2M +158.19% | 34.6M -4.10% | 36.0M +45.98% | 24.7M -25.39% | |
Short-Term Investments | N/A N/A | N/A N/A | 0 -100.00% | 51.1M -25.61% | |
Cash and Cash Equivalents and Short-Term Investments | 89.2M +158.19% | 34.6M -4.10% | 36.0M -52.47% | 75.8M -25.54% | |
Total Current Assets | 91.6M +135.18% | 38.9M -5.35% | 41.1M -49.41% | 81.3M -22.71% | |
Accumulated Depreciation | 8.4M +6.73% | 7.8M +6.50% | 7.4M -35.11% | 11.4M +19.01% | |
Property and Plant and Equipment and Net | 433,000 -22.95% | 562,000 -71.46% | 2.0M -45.76% | 3.6M -24.28% | |
Total Long-Term Assets | 46,000 -86.10% | 331,000 -17.66% | 402,000 -51.39% | 827,000 +50.64% | |
Total Assets | 98.7M +103.70% | 48.5M +5.18% | 46.1M -48.48% | 89.4M -34.80% | |
Income Taxes Payable | 7.9M +52.74% | 5.2M +25.55% | 4.1M -39.75% | 6.8M -20.94% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 9.9M +35.75% | 7.3M +2.34% | 7.1M -26.55% | 9.7M -28.30% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 276.6M +342.27% | 62.5M +6,172.02% | 997,000 -73.07% | 3.7M -73.37% | |
Total Liabilities | 286.5M +310.17% | 69.8M +757.54% | 8.1M -39.37% | 13.4M -51.10% | |
Retained Earnings | -527.3M +84.84% | -285.3M +28.67% | -221.7M +24.09% | -178.7M +25.24% | |
Total Stockholders Equity | -187.8M +778.21% | -21.4M -156.36% | 37.9M -50.09% | 76.0M -30.72% | |
Total Shares Outstanding | 9.8M +199.66% | 3.3M +58.12% | 2.1M -93.14% | 30.1M -14.12% | |
Cash Flow | |||||
Cash from Operating Activities | -30.2M +71.57% | -17.6M -56.33% | -40.4M -8.57% | -44.1M -9.56% | |
Capital Expenditures | 128,000 +392.31% | 26,000 -93.47% | 398,000 -45.33% | 728,000 -42.63% | |
Cash from Investing Activities | -128,000 +392.31% | -26,000 -100.05% | 51.7M +35.02% | 38.3M +149.30% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 85.1M +425.79% | 16.2M +5,760.87% | 276,000 +110.76% | -2.6M -102.06% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -1,210.58% +405.06% | -239.69% -98.74% | -18,995.85% -152.27% | 36,343.44% -20.49% | |
Return on Assets | -328.86% +144.57% | -134.46% +111.67% | -63.52% +99.91% | -31.78% -32.85% | |
Return on Equity | 231.45% +130.14% | -767.91% +916.37% | -75.55% +94.85% | -38.78% -59.31% | |
Revenue Growth | -67.37% -101.56% | 4,321.16% +1,352.29% | 297.54% +11,902.50% | -2.52% -99.81% | |
Current Ratio | 9.22 +73.24% | 5.32 -7.51% | 5.75 -31.12% | 8.35 +7.80% | |
Cash Ratio | 8.99 +90.20% | 4.73 -6.29% | 5.04 +98.75% | 2.54 +4.06% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow